In California, Codexis will be delivering a positive cash flow in 2014 according to recently released financial results for its second quarter. Revenues for the quarter ended June 30, 2014 were $6.6 million, a 6% decrease from $7.0 million of revenues recorded in the second quarter of 2013. According to President and CEO John Nicols, “After delivering results in line […]
In California, Codexis announced the signing of a platform technology license agreement with GlaxoSmithKline (GSK). Under the terms of the agreement, Codexis granted GSK a license to use Codexis’ proprietary CodeEvolver® protein engineering platform technology in the field of human healthcare. The license allows GSK to use Codexis’ platform technology to develop novel enzymes for […]
Traveling through the seasons with Calysta Energy chairman and CEO Alan Shaw, from the summer of IPOs with Codexis — and now back into springtime, courtesy of a technology that plays cheap natural gas. For eight o’clock in the morning on the last day of a long BIO Pac Rim conference, Alan Shaw was looking […]
In California, Codexis announced that the company has received notice from Dyadic International, Inc. alleging that Codexis is in breach under a license agreement established by the companies on November 14, 2008. According to the notice, Dyadic intends to terminate the agreement in 60 days if the breach is not cured to Dyadic’s satisfaction. Codexis […]
In Italy, Chemtex and Codexis announced the successful scale-up in the production of CodeXol detergent alcohols using cellulosic sugars. The scale-up was achieved at a 1,500 liter demonstration facility at Chemtex’s R&D complex in Tortona, Italy and is a key milestone in the ongoing effort initiated by the two companies to develop a fully integrated […]
In Canada, CO2 Solutions announced that it has renewed until March 31, 2015 its Joint Development Agreement with Codexis to continue the development and deployment of CO2 Solutions’ enzymatic carbon capture technology. Under the amended and restated JDA, CO2 Solutions’ proprietary enzymatic method for the efficient capture of carbon dioxide from large emission sources will continue to benefit from Codexis’ […]
In California, Codexis reports revenues for the first quarter of 2013 were $11.5 million, a 45% increase from $7.9 million in the fourth quarter of 2012. Net operating costs were $21.1 million, a nearly 11% decrease from the fourth quarter of 2012. The net loss was $9.6 million, or a loss of $0.25 per share, […]
In California, former CEO of Codexis and current CEO of Calysta Energy Alan Shaw now says that it’s not economical to produce next generation fuels from crops, so has switched to natural gas as feedstock. He says that falling gas prices thanks to shale gas to funneling funds that had been going to biofuel technology […]
Compared to prior generations, CodeXyme 4 and CodeXyme 4X significantly reduce the cost of cellulosic sugar production for biofuels and bio‐based chemicals. In California, Codexis announced the launch of CodeXyme 4 and CodeXyme 4X cellulase enzyme packages for use in producing cellulosic sugar for production of biofuels and bio‐based chemicals. Codexis’ latest generation of advanced […]
In Massachusetts, Strem Chemicals and Codexis have signed an enzyme distribution agreement, in which Strem receives exclusive distribution rights for the new 100mg CODEX Screening Kits for Codexis’ popular Transaminase and Ketoreductase enzyme platforms. These enzymes enable efficient conversion of ketones to chiral alcohols or amines. The screening kits contain enzymes evolved with proprietary CodeEvolver […]
